Lisa M. Stanton - 19 Dec 2025 Form 4 Insider Report for Red Violet, Inc. (RDVT)

Role
Director
Signature
/s/ Lisa Stanton
Issuer symbol
RDVT
Transactions as of
19 Dec 2025
Net transactions value
$0
Form type
4
Filing time
22 Dec 2025, 18:59:26 UTC
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stanton Lisa M. Director C/O RED VIOLET, INC., 2650 N. MILITARY TRAIL, SUITE 300, BOCA RATON /s/ Lisa Stanton 22 Dec 2025 0001858445

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RDVT Common Stock Award +4,450 +17% 31,265 19 Dec 2025 Direct F1, F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 19, 2025, the reporting person received a grant of 4,450 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 2,130 RSUs for serving as a member of the Company's Board of Directors, 1,625 RSUs for serving as a member of the Audit Committee and 695 RSUs for serving as the Chair of the Audit Committee.
F2 Includes 1,666 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026.
F3 Includes 1,333 RSUs originally granted on April 23, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026.
F4 Includes 4,480 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.
F5 Includes 644 RSUs originally granted on March 4, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.